Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06766916Phase 2Recruiting
A Phase 2 trial of crisugabalin besilate in neuropathic pain, sponsored by Sun Yat-sen Memorial Hospital. Started May 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06766916.